adfrar

Adfraradaz injection is indicated for the treatment and prevention of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis It is effectively used for children aged 4 years and older with juvenile idiopathic arthritis Additionally Adfraradaz is commonly prescribed for the management of psoriatic arthritis a condition characterized by joint pain swelling and scaly patches on the skin This type of arthritis is often associated with psoriasis a skin disorder Adfraradaz can be administered as a standalone treatment or in combination with other medications like methotrexate Moreover Adfraradaz injection is also utilized for alleviating the symptoms of active Crohns disease in adult patients who have not responded well to alternative therapies including infliximab In addition it is employed for the management of moderate to severe cases of ulcerative colitis in patients who have been previously treated with other medications such as azathioprine corticosteroids or 6mercaptopurine without satisfactory results